# Phio Pharmaceuticals Corp.: Form 8-K, filed Mar 30, 2026

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2026-03-30
- Accepted by EDGAR: Mar 30, 2026, 11:15 ET
- Period: 2026-03-30
- Accession: 0001437749-26-010164
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000143774926010164/phio20260326_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000143774926010164/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000143774926010164/phio20260326_8k.htm

Filed Mar 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-010164. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.